Parkinson's disease
Parkinson's Disease Progression Linked to Five Variants in Genome-Wide Survival Study
The researchers also developed a polygenic hazard score to predict which individuals with Parkinson's are likely to develop disease-related dementia.
Valted Seq Lands Exclusive Rights to Evaluate Johns Hopkins Neurodegenerative Disease Dx Assays
The biomarker assays could one day be used as companion diagnostics for new treatments of Parkinson's and related diseases.
Centogene Q4 Revenues Grow Almost Fivefold, Driven by COVID-19 Testing
For 2020, the company reported €128.4 million in revenues, including €89.3 million from COVID-19 testing, more than doubling its 2019 revenues of €48.8 million.
Microba, University of Queensland Partner to Study Gut Microbiome in Parkinson's Disease
The partners will use Microba's technologies to examine the link between the gut microbiome and Parkinson's disease in animal models and in patients.
Genuity Science, Emory Team on Biomarker Discovery for Neurodegenesis
The bioinformatics and sequencing firm, formerly known as WuXi NextCode, will develop a population clinicogenomic database to support Emory's research.
Oct 24, 2019
Jul 17, 2019
Dec 20, 2018